"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"

NCT02348606 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

476

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea

Interventions

DRUG: JZP-110
DRUG: Placebo oral tablet

Sponsor

Jazz Pharmaceuticals